Cargando…
Development of a cartilage composite utilizing porous tantalum, fibrin, and rabbit chondrocytes for treatment of cartilage defect
OBJECTIVE: Functional tissue engineering has emerged as a potential means for treatment of cartilage defect. Development of a stable cartilage composite is considered to be a good option. The aim of the study was to observe whether the incorporation of cultured chondrocytes on porous tantalum utiliz...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327955/ https://www.ncbi.nlm.nih.gov/pubmed/25889942 http://dx.doi.org/10.1186/s13018-015-0166-z |
_version_ | 1782357164296241152 |
---|---|
author | Jamil, Kamal Chua, Kien-Hui Joudi, Samad Ng, Sook-Luan Yahaya, Nor Hamdan |
author_facet | Jamil, Kamal Chua, Kien-Hui Joudi, Samad Ng, Sook-Luan Yahaya, Nor Hamdan |
author_sort | Jamil, Kamal |
collection | PubMed |
description | OBJECTIVE: Functional tissue engineering has emerged as a potential means for treatment of cartilage defect. Development of a stable cartilage composite is considered to be a good option. The aim of the study was to observe whether the incorporation of cultured chondrocytes on porous tantalum utilizing fibrin as a cell carrier would promote cartilage tissue formation. METHODS: Rabbit articular chondrocytes were cultured and seeded onto tantalum with fibrin as temporary matrix in a composite, which was divided into three groups. The first group was kept in vitro while a total of 12 constructs were implanted into the dorsum of mice for the second and third groups. The implanted tissues were harvested after 4 weeks (second group) and after 8 weeks (third group). Specific characteristic of cartilage growth were studied by histological and biochemical assessment, immunohistochemistry, and quantitative PCR analysis. RESULTS: Histological and biochemical evaluation of the formed cartilage using hematoxylin and eosin and Alcian blue staining showed lacunae chondrocytes embedded in the proteoglycan rich matrix. Dimethylmethylene blue assay demonstrated high glycosaminoglycans content in the removed tissue following 8 weeks of implantation. Immunohistochemistry results showed the composites after implantation expressed high collagen type II. Quantitative PCR results confirmed a significant increase in cartilage associated genes expression (collagen type II, AggC, Sox 9) after implantation. CONCLUSION: Tantalum scaffold with fibrin as cell carrier promotes chondrocyte proliferation and cartilaginous tissue formation. Producing hyaline cartilage within a stable construct of tantalum and fibrin has a potential for treatment of cartilage defect. |
format | Online Article Text |
id | pubmed-4327955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43279552015-02-15 Development of a cartilage composite utilizing porous tantalum, fibrin, and rabbit chondrocytes for treatment of cartilage defect Jamil, Kamal Chua, Kien-Hui Joudi, Samad Ng, Sook-Luan Yahaya, Nor Hamdan J Orthop Surg Res Research Article OBJECTIVE: Functional tissue engineering has emerged as a potential means for treatment of cartilage defect. Development of a stable cartilage composite is considered to be a good option. The aim of the study was to observe whether the incorporation of cultured chondrocytes on porous tantalum utilizing fibrin as a cell carrier would promote cartilage tissue formation. METHODS: Rabbit articular chondrocytes were cultured and seeded onto tantalum with fibrin as temporary matrix in a composite, which was divided into three groups. The first group was kept in vitro while a total of 12 constructs were implanted into the dorsum of mice for the second and third groups. The implanted tissues were harvested after 4 weeks (second group) and after 8 weeks (third group). Specific characteristic of cartilage growth were studied by histological and biochemical assessment, immunohistochemistry, and quantitative PCR analysis. RESULTS: Histological and biochemical evaluation of the formed cartilage using hematoxylin and eosin and Alcian blue staining showed lacunae chondrocytes embedded in the proteoglycan rich matrix. Dimethylmethylene blue assay demonstrated high glycosaminoglycans content in the removed tissue following 8 weeks of implantation. Immunohistochemistry results showed the composites after implantation expressed high collagen type II. Quantitative PCR results confirmed a significant increase in cartilage associated genes expression (collagen type II, AggC, Sox 9) after implantation. CONCLUSION: Tantalum scaffold with fibrin as cell carrier promotes chondrocyte proliferation and cartilaginous tissue formation. Producing hyaline cartilage within a stable construct of tantalum and fibrin has a potential for treatment of cartilage defect. BioMed Central 2015-02-07 /pmc/articles/PMC4327955/ /pubmed/25889942 http://dx.doi.org/10.1186/s13018-015-0166-z Text en © Jamil et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Jamil, Kamal Chua, Kien-Hui Joudi, Samad Ng, Sook-Luan Yahaya, Nor Hamdan Development of a cartilage composite utilizing porous tantalum, fibrin, and rabbit chondrocytes for treatment of cartilage defect |
title | Development of a cartilage composite utilizing porous tantalum, fibrin, and rabbit chondrocytes for treatment of cartilage defect |
title_full | Development of a cartilage composite utilizing porous tantalum, fibrin, and rabbit chondrocytes for treatment of cartilage defect |
title_fullStr | Development of a cartilage composite utilizing porous tantalum, fibrin, and rabbit chondrocytes for treatment of cartilage defect |
title_full_unstemmed | Development of a cartilage composite utilizing porous tantalum, fibrin, and rabbit chondrocytes for treatment of cartilage defect |
title_short | Development of a cartilage composite utilizing porous tantalum, fibrin, and rabbit chondrocytes for treatment of cartilage defect |
title_sort | development of a cartilage composite utilizing porous tantalum, fibrin, and rabbit chondrocytes for treatment of cartilage defect |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327955/ https://www.ncbi.nlm.nih.gov/pubmed/25889942 http://dx.doi.org/10.1186/s13018-015-0166-z |
work_keys_str_mv | AT jamilkamal developmentofacartilagecompositeutilizingporoustantalumfibrinandrabbitchondrocytesfortreatmentofcartilagedefect AT chuakienhui developmentofacartilagecompositeutilizingporoustantalumfibrinandrabbitchondrocytesfortreatmentofcartilagedefect AT joudisamad developmentofacartilagecompositeutilizingporoustantalumfibrinandrabbitchondrocytesfortreatmentofcartilagedefect AT ngsookluan developmentofacartilagecompositeutilizingporoustantalumfibrinandrabbitchondrocytesfortreatmentofcartilagedefect AT yahayanorhamdan developmentofacartilagecompositeutilizingporoustantalumfibrinandrabbitchondrocytesfortreatmentofcartilagedefect |